CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 35 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,629,000 | -12.4% | 941,348 | -1.8% | 0.08% | -7.1% |
| Q3 2016 | $1,860,000 | +11.5% | 958,822 | 0.0% | 0.08% | -7.6% |
| Q2 2016 | $1,668,000 | +28.8% | 958,822 | -0.0% | 0.09% | +29.6% |
| Q1 2016 | $1,295,000 | -22.9% | 958,920 | -3.5% | 0.07% | -13.4% |
| Q4 2015 | $1,680,000 | -8.8% | 993,920 | +4.6% | 0.08% | -7.9% |
| Q3 2015 | $1,843,000 | – | 950,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |